• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA28-70/I16-30
Medical Device Problem Code Separation Problem (4043)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 09/03/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2.
 
Event or Problem Description
The patient was initially implanted with an afx2 bifurcated stent graft, a vela suprarenal stent graft extension, a non-endologix device (excluder cuff) and a non-endologix smart bare metal stent to treat an abdominal aortic aneurysm (aaa).This procedure is outside the indications of use (off-label) due to the use of adjunctive devices not compatible with afx system per the ifu.Approximately 2 years later, a follow up computed tomography (ct) scan identified junction separation and a type 3a endoleak.The physician completed a successful reintervention and relined the existing stent grafts with a vela infrarenal stent graft extension and an additional excluder cuff.The endoleak was resolved and no patient harm was reported.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.There are no other equivalent adverse events/incidents for this lot number existing within the endologix complaint handling system.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the type iiia endoleak of the endologix aortic components is confirmed.This is consistent with the reported adverse event/incident.The most likely causation for the type iiia endoleak is user related due to the concomitant product use of a non-endologix stent placed first in the proximal neck.The final patient status remains unknown.The final patient status was not made available to endologix.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key10600144
Report Number2031527-2020-00276
Device Sequence Number3287612
Product Code MIH
UDI-Device Identifier00818009014603
UDI-Public(01)00818009014603(17)190314
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source distributor,foreign,other
Initial Reporter Occupation Physician
Remedial Action Other,Recall
Type of Report Initial,Followup
Report Date (Section B) 09/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/14/2020
Device Model NumberBEA28-70/I16-30
Device Lot Number1822025006
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 09/08/2020
Supplement Date Received by Manufacturer11/11/2020
Initial Report FDA Received Date09/29/2020
Supplement Report FDA Received Date12/01/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0007-2019
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NON-ENDOLOGIX DEVICE (EXCLUDER CUFF); NON-ENDOLOGIX DEVICE (SMART BARE METAL STENT); VELA SUPRARENAL, LOT# 1822795003; NON-ENDOLOGIX DEVICE (EXCLUDER CUFF); NON-ENDOLOGIX DEVICE (SMART BARE METAL STENT); VELA SUPRARENAL, LOT# 1822795003
Outcome Attributed to Adverse Event Required Intervention;
Patient Age72 YR
-
-